TC
RLYB icon

Truvestments Capital’s Rallybio RLYB Stock Holding History

Truvestments Capital’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Buy
+129
New +$1.66K ﹤0.01% 1015

Other funds holding RLYB

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Truvestments Capital's RLYB Position: Q2 2026 in Review

Truvestments Capital opened a new position in Rallybio (RLYB) in Q2 2026: 129 shares worth $2.06K. The stake represents ﹤0.01% of the portfolio and ranks #1015 among its holdings.

37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Truvestments Capital held 129 shares of Rallybio worth $2.06K as of Q2 2026.
  • Rallybio was a new Truvestments Capital position in Q2 2026.
  • Rallybio made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1015 holding.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.